Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience. Journal of Kidney Cancer, [S. l.], v. 12, n. 3, p. 25–31, 2025. DOI: 10.15586/jkcvhl.v12i3.425. Disponível em: https://jkcvhl.com/index.php/jkcvhl/article/view/425. Acesso em: 12 nov. 2025.